Julia P Gregory insider trades
Open-market stock purchases and sales by Julia P Gregory, Director at Nurix Therapeutics, Inc, from SEC Form 4 filings since Sep 11, 2014.
Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +12%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Oct 14, 2026 | NRIX Nurix Therapeutics, Inc | Bought (not open market) | $42K |
| Oct 14, 2026 | NRIX Nurix Therapeutics, Inc | Sold | $529K |
| Oct 14, 2026 | NRIX Nurix Therapeutics, Inc | Bought (not open market) | — |
| May 15, 2026 | NRIX Nurix Therapeutics, Inc | Bought (not open market) | — |
| Apr 28, 2026 | BHVN Biohaven Ltd | Bought (not open market) | — |